SI-Bone received FDA clearance for a new device, the iFuse Bedrock technology, according to a press release published by Seeking Alpha.
Three key notes:
1. The new technology is designed for sacroiliac joint fusions that require long construct procedures. The technology can provide greater joint stabilization.
2. SI-Bone previously received clearance for the iFuse minimally invasive sacroiliac joint procedures with the dorsal implantation approach. The broadened indication allows surgeons to place iFuse Bedrock across the sacroiliac joint during long fusions.
3. More than 68 peer-reviewed publications provide clinical evidence supporting the legacy SI-Bone technology, including six-year data.